Literature DB >> 25870189

Angiotensin II activates the RhoA exchange factor Arhgef1 in humans.

Maria Luigia Carbone1, Jérémy Brégeon1, Nabila Devos1, Gilliane Chadeuf1, Anne Blanchard1, Michel Azizi1, Pierre Pacaud1, Xavier Jeunemaître1, Gervaise Loirand2.   

Abstract

Although a causative role for RhoA-Rho kinase has been recognized in the development of human hypertension, the molecular mechanism(s) and the RhoA guanine exchange factor(s) responsible for the overactivation of RhoA remain unknown. Arhgef1 was identified as a RhoA guanine exchange factor involved in angiotensin II (Ang II)-mediated regulation of vascular tone and hypertension in mice. The aim of this study was to determine whether Arhgef1 is activated and involved in the activation of RhoA-Rho kinase signaling by Ang II in humans. In vitro stimulation of human coronary artery smooth muscle cells and human peripheral blood mononuclear cells by Ang II (0.1 μmol/L) induced activation of Arhgef1 attested by its increased tyrosine phosphorylation. Silencing of Arhgef1 expression by siRNA inhibited Ang II-induced activation of RhoA-Rho kinase signaling. In normotensive subjects, activation of the renin-angiotensin system by a low-salt diet for 7 days increased RhoA-Rho kinase signaling and stimulated Arhgef1 activity in peripheral blood mononuclear cells. In conclusion, our results strongly suggest that Arhgef1 mediates Ang II-induced RhoA activation in humans. Moreover, they show that measurement of RhoA guanine exchange factor activity in peripheral blood mononuclear cells might be a useful method to evaluate RhoA guanine exchange factor activity in humans.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  Rho GTP-binding proteins; Rho guanine nucleotide exchange factors; angiotensins; arteries; hypertension; leukocytes; signal transduction

Mesh:

Substances:

Year:  2015        PMID: 25870189     DOI: 10.1161/HYPERTENSIONAHA.114.05065

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

1.  Leukocyte RhoA exchange factor Arhgef1 mediates vascular inflammation and atherosclerosis.

Authors:  Maria Luigia Carbone; Gilliane Chadeuf; Sandrine Heurtebise-Chrétien; Xavier Prieur; Thibault Quillard; Yann Goueffic; Nathalie Vaillant; Marc Rio; Laure Castan; Maxim Durand; Céline Baron-Menguy; Julien Aureille; Juliette Desfrançois; Angela Tesse; Raul M Torres; Gervaise Loirand
Journal:  J Clin Invest       Date:  2017-11-13       Impact factor: 14.808

Review 2.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

3.  p115 RhoGEF activates the Rac1 GTPase signaling cascade in MCP1 chemokine-induced vascular smooth muscle cell migration and proliferation.

Authors:  Nikhlesh K Singh; Jagadeesh Janjanam; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2017-06-27       Impact factor: 5.157

Review 4.  Regulation of myosin light-chain phosphorylation and its roles in cardiovascular physiology and pathophysiology.

Authors:  Masaaki Ito; Ryuji Okamoto; Hiromasa Ito; Ye Zhe; Kaoru Dohi
Journal:  Hypertens Res       Date:  2021-10-06       Impact factor: 3.872

Review 5.  Druggable targets in the Rho pathway and their promise for therapeutic control of blood pressure.

Authors:  Rachel A Dee; Kevin D Mangum; Xue Bai; Christopher P Mack; Joan M Taylor
Journal:  Pharmacol Ther       Date:  2018-09-04       Impact factor: 12.310

6.  Structural Design and Analysis of the RHOA-ARHGEF1 Binding Mode: Challenges and Applications for Protein-Protein Interface Prediction.

Authors:  Ennys Gheyouche; Matthias Bagueneau; Gervaise Loirand; Bernard Offmann; Stéphane Téletchéa
Journal:  Front Mol Biosci       Date:  2021-05-24

7.  Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension.

Authors:  S A Potthoff; S Stamer; K Grave; E Königshausen; S H Sivritas; M Thieme; Y Mori; M Woznowski; L C Rump; J Stegbauer
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-07-12       Impact factor: 1.636

8.  Tyrosine kinases as key modulators of smooth muscle function in health and disease.

Authors:  G A Knock
Journal:  J Physiol       Date:  2015-09-01       Impact factor: 5.182

9.  Adiponectin Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Remodeling through Nitric Oxide and the RhoA/ROCK Pathway.

Authors:  Wared Nour-Eldine; Crystal M Ghantous; Kazem Zibara; Leila Dib; Hawraa Issaa; Hana A Itani; Nabil El-Zein; Asad Zeidan
Journal:  Front Pharmacol       Date:  2016-04-07       Impact factor: 5.810

Review 10.  Vascular smooth muscle contraction in hypertension.

Authors:  Rhian M Touyz; Rheure Alves-Lopes; Francisco J Rios; Livia L Camargo; Aikaterini Anagnostopoulou; Anders Arner; Augusto C Montezano
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.